Chitin-glucan supplementation improved postprandial metabolism and altered gut microbiota in subjects at cardiometabolic risk in a randomized trial.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 05 2022
Historique:
received: 15 02 2022
accepted: 05 05 2022
entrez: 25 5 2022
pubmed: 26 5 2022
medline: 28 5 2022
Statut: epublish

Résumé

Chitin-glucan (CG), an insoluble dietary fiber, has been shown to improve cardiometabolic disorders associated with obesity in mice. Its effects in healthy subjects has recently been studied, revealing its interaction with the gut microbiota. In this double-blind, randomized, cross-over, twice 3-week exploratory study, we investigated the impacts of CG on the cardiometabolic profile and gut microbiota composition and functions in 15 subjects at cardiometabolic risk. They consumed as a supplement 4.5 g of CG daily or maltodextrin as control. Before and after interventions, fasting and postprandial metabolic parameters and exhaled gases (hydrogen [H

Identifiants

pubmed: 35614185
doi: 10.1038/s41598-022-12920-z
pii: 10.1038/s41598-022-12920-z
pmc: PMC9132890
doi:

Substances chimiques

Blood Glucose 0
Chitin 1398-61-4
Dietary Fiber 0
Glucans 0
RNA, Ribosomal, 16S 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8830

Informations de copyright

© 2022. The Author(s).

Références

J Nutr Biochem. 2012 Jan;23(1):51-9
pubmed: 21411304
Mol Nutr Food Res. 2015 Aug;59(8):1603-13
pubmed: 25820326
Appl Environ Microbiol. 2015 Nov;81(22):7945-56
pubmed: 26386056
Biomed Environ Sci. 2015 Mar;28(3):239-41
pubmed: 25800452
Sci Rep. 2016 Jan 22;6:19694
pubmed: 26795945
Nutr Bull. 2020 Mar;45(1):59-65
pubmed: 32194343
Gastroenterol Hepatol (N Y). 2012 Jan;8(1):22-8
pubmed: 22347829
Diabetes Care. 1997 Apr;20(4):545-50
pubmed: 9096978
Nature. 2006 Dec 21;444(7122):1027-31
pubmed: 17183312
Genes Nutr. 2017 Aug 29;12:21
pubmed: 28861127
Cell Host Microbe. 2020 Mar 11;27(3):389-404.e6
pubmed: 32004499
Eur Rev Med Pharmacol Sci. 2005 Jul-Aug;9(4):191-208
pubmed: 16128039
Int J Food Microbiol. 2011 Sep 1;149(1):73-80
pubmed: 21450362
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Br J Nutr. 2010 Feb;103(3):422-8
pubmed: 19781120
J Agric Food Chem. 2009 Feb 11;57(3):1093-8
pubmed: 19154104
Obesity (Silver Spring). 2011 Jul;19(7):1396-403
pubmed: 21293445
Diabetes Care. 2006 Mar;29(3):571-4
pubmed: 16505508
Gut Microbes. 2020 Nov 9;12(1):1810530
pubmed: 32893709
J Am Coll Cardiol. 2002 Jan 2;39(1):49-56
pubmed: 11755286
Diabetologia. 2006 May;49(5):846-54
pubmed: 16532323
Nat Biotechnol. 2017 Nov;35(11):1069-1076
pubmed: 28967887
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
pubmed: 17586664
Br J Nutr. 2007 Sep;98(3):458-73
pubmed: 17705891
Nat Rev Gastroenterol Hepatol. 2021 Feb;18(2):101-116
pubmed: 33208922
Microbiol Spectr. 2017 Sep;5(5):
pubmed: 28936943
JAMA. 1999 Jun 2;281(21):1998-2004
pubmed: 10359388
Am J Cardiol. 2007 Sep 1;100(5):899-904
pubmed: 17719342
Annu Rev Food Sci Technol. 2016;7:167-90
pubmed: 26735801
Ugeskr Laeger. 2008 Jan 28;170(5):328-30
pubmed: 18252159
Microbiol Mol Biol Rev. 1997 Jun;61(2):262-80
pubmed: 9184013
Br J Nutr. 1994 Nov;72(5):731-43
pubmed: 7826996
J Nutr. 2004 Aug;134(8):1881-6
pubmed: 15284370
J Clin Endocrinol Metab. 2013 Apr;98(4):E698-702
pubmed: 23533244
Diabetes Care. 2010 Sep;33(9):2077-83
pubmed: 20573752
Gut. 1990 Jun;31(6):684-5
pubmed: 2379872
Nutr Res Rev. 2017 Dec;30(2):149-190
pubmed: 28676135
Front Physiol. 2015 Aug 07;6:216
pubmed: 26300782
Eur J Clin Nutr. 2013 Jan;67(1):2-7
pubmed: 22948945
Appl Environ Microbiol. 2002 Oct;68(10):5186-90
pubmed: 12324374
Nutr Res. 2008 Mar;28(3):137-43
pubmed: 19083400
Eur J Clin Nutr. 2001 May;55(5):327-33
pubmed: 11378805
Nat Biotechnol. 2019 Aug;37(8):852-857
pubmed: 31341288
Nutrients. 2021 May 13;13(5):
pubmed: 34068353
Mol Nutr Food Res. 2009 Mar;53(3):361-9
pubmed: 18837470
J Nutr Biochem. 2018 Nov;61:101-110
pubmed: 30196242

Auteurs

Harimalala Ranaivo (H)

Centre de Recherche en Nutrition Humaine Rhône-Alpes, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, Pierre-Bénite, France.
Univ-Lyon, CarMeN Laboratory, INSERM, INRAE, Université Claude Bernard Lyon-1, 69600, Oullins, France.

Zhengxiao Zhang (Z)

College of Food and Biological Engineering, Jimei University, Xiamen, Fujian, China.

Maud Alligier (M)

Centre de Recherche en Nutrition Humaine Rhône-Alpes, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, Pierre-Bénite, France.
Univ-Lyon, CarMeN Laboratory, INSERM, INRAE, Université Claude Bernard Lyon-1, 69600, Oullins, France.

Laurie Van Den Berghe (L)

Centre de Recherche en Nutrition Humaine Rhône-Alpes, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, Pierre-Bénite, France.
Univ-Lyon, CarMeN Laboratory, INSERM, INRAE, Université Claude Bernard Lyon-1, 69600, Oullins, France.

Monique Sothier (M)

Centre de Recherche en Nutrition Humaine Rhône-Alpes, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, Pierre-Bénite, France.
Univ-Lyon, CarMeN Laboratory, INSERM, INRAE, Université Claude Bernard Lyon-1, 69600, Oullins, France.

Stéphanie Lambert-Porcheron (S)

Centre de Recherche en Nutrition Humaine Rhône-Alpes, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, Pierre-Bénite, France.
Univ-Lyon, CarMeN Laboratory, INSERM, INRAE, Université Claude Bernard Lyon-1, 69600, Oullins, France.

Nathalie Feugier (N)

Centre de Recherche en Nutrition Humaine Rhône-Alpes, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, Pierre-Bénite, France.
Univ-Lyon, CarMeN Laboratory, INSERM, INRAE, Université Claude Bernard Lyon-1, 69600, Oullins, France.

Charlotte Cuerq (C)

Univ-Lyon, CarMeN Laboratory, INSERM, INRAE, Université Claude Bernard Lyon-1, 69600, Oullins, France.
Service de Biochimie et Biologie Moléculaire, Unité Médicale Dyslipidémies et Dysfonctions Nutritionnelles et Digestives, Hospices Civils de Lyon, Pierre-Bénite, France.

Christelle Machon (C)

Hospices Civils de Lyon, Service de Biochimie, Centre de Biologie Sud, Hôpital Lyon Sud, Pierre-Bénite, France.

Audrey M Neyrinck (AM)

Metabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain, Ottignies-Louvain-la-Neuve, Belgium.

Benjamin Seethaler (B)

Institute of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany.

Julie Rodriguez (J)

Metabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain, Ottignies-Louvain-la-Neuve, Belgium.

Martin Roumain (M)

Bioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain, Brussels, Belgium.

Giulio G Muccioli (GG)

Bioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain, Brussels, Belgium.

Véronique Maquet (V)

KitoZyme, Parc Industriel des Hauts-Sart, Zone 2, Rue de Milmort 680, 4040, Herstal, Belgium.

Martine Laville (M)

Centre de Recherche en Nutrition Humaine Rhône-Alpes, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, Pierre-Bénite, France.
Univ-Lyon, CarMeN Laboratory, INSERM, INRAE, Université Claude Bernard Lyon-1, 69600, Oullins, France.

Stephan C Bischoff (SC)

Institute of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany.

Jens Walter (J)

Department of Medicine, and School of Microbiology, APC Microbiome Ireland, University College Cork, Cork, Ireland.

Nathalie M Delzenne (NM)

Metabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain, Ottignies-Louvain-la-Neuve, Belgium.

Julie-Anne Nazare (JA)

Centre de Recherche en Nutrition Humaine Rhône-Alpes, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, Pierre-Bénite, France. julie-anne.nazare@univ-lyon1.fr.
Univ-Lyon, CarMeN Laboratory, INSERM, INRAE, Université Claude Bernard Lyon-1, 69600, Oullins, France. julie-anne.nazare@univ-lyon1.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH